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X chromosome inactivation (XCI) is a female-speciﬁc mechanism that
serves to balance gene dosage between the sexes whereby one X
chromosome in females is inactivated during early development.
Despite this silencing, a small portion of genes escape inactivation and
remain expressed from the inactive X (Xi). Little is known about the
distribution of escape from XCI in different tissues in vivo and about
the mechanisms that control tissue-speciﬁc differences. Using a new
binomial model in conjunction with a mouse model with identiﬁable
alleles and skewed X inactivation we are able to survey genes that
escape XCI in vivo. We show that escape from X inactivation can be a
common feature of some genes, whereas others escape in a tissue
speciﬁc manner. Furthermore, we characterize the chromatin envir-
onment of escape genes and show that expression from the Xi cor-
relates with factors associated with open chromatin and that CTCF co-
localizes with escape genes. Here, we provide a detailed description of
the experimental design and data analysis pipeline we used to assay
allele-speciﬁc expression and epigenetic characteristics of genes
escaping X inactivation. The data is publicly available through the GEO
database under ascension numbers GSM1014171, GSE44255, and
GSE59779. Interpretation and discussion of these data are included in
a previously published study (Berletch et al., 2015) [1].
& 2015 The Authors. Published by Elsevier Inc. This is an open access
article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).vier Inc. This is an open access article under the CC BY license
logy, University of Washington, Seattle, WA, USA.
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Table 1
Datasets and correspondin
Sample Replicate
Brain 1
Brain 2
Spleen 1
Spleen 2
Ovary 1
Patski 1a
Patski 2a
Brain 1
Brain 1
Patski 1
Patski 1
Patski 1b
Patski 2b
a Patski cell RNA-seq, d
b Analysis was done usrganism/cell line/
tissueMus musculus (C57BL/6J) x Mus spretus F1 whole brain, whole spleen, whole
ovary, and Patski ﬁbroblasts derived from embryonic kidneyex Female
equencer or array
typeIllumina HiSeq 2000 and Illumina Genome Analyzer IIxata format DNase-seq: BROADPEAK, NARROWPEAK, BIGWIG; ChIP-seq: BED, BIGWIG; RNA-
seq: BIGWIG, TXTxperimental
factorsAdult tissues (brain, spleen, ovary) in which the Xi is from spretus, and Patski
ﬁbroblast cell line in which the Xi is from BL6.xperimental
featuresRNA-seq to identify genes escaping X chromosome inactivation in a tissue-speciﬁc
manner, and DNase-seq and ChIP-seq to identify molecular mechanisms involved
in escape.onsent NA
ample source
locationRiken Institute, Japan and Jackson Laboratory, USADirect link to deposited data
The Patski cell DNase-seq and RNA-seq data is available through GEO series GSM970866 and
GSM1014171, respectively, and ENCODE data portals:
https://www.encodeproject.org
http://www.mouseencode.org
The ChIP-seq data for RNA polymerase PolII-S5p occupancy in brain and Patski cells are available
under GSE44255:
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc¼GSE44255
The RNA-seq data for tissues and ChIP-seq data for CTCF binding in brain and Patski cells are
available under GSE59779:
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc¼GSE59779
Individual dataset descriptions can be found in Table 1.g URLs.
Feature Upload URLs
RNA-seq http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc¼GSM1446324
RNA-seq http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc¼GSM1446325
RNA-seq http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc¼GSM1446326
RNA-seq http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc¼GSM1446327
RNA-seq http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc¼GSM1446328
RNA-seq https://www.encodeproject.org/experiments/ENCSR000CLX/
RNA-seq http://www.ncbi.nlm.nih.gov/sra?term¼SRA010053
CTCF ChIP-seq http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc¼GSM1446329
PolII ChIP-seq http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc¼GSM1081374
CTCF ChIP-seq http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc¼GSM1446330
PolII ChIP-seq http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc¼GSM1446331
Dnase-seq https://www.encodeproject.org/experiments/ENCSR000CNT/
Dnase-seq https://www.encodeproject.org/experiments/ENCSR000CNT/
ata deposited by ENCODE (1) and data from [4] (2) re-analyzed using our new binomial model.
ing two replicates of DNase-seq data deposited by ENCODE.
J.B. Berletch et al. / Data in Brief 5 (2015) 761–769 7631. Value of the data The data describe tissue speciﬁc escape gene proﬁles, discovery of which could lead to insights into
the contribution of escape genes in sex chromosome aneuploidy such as Turner syndrome and in
sex differences in general.
 The data show that tissue speciﬁc escape genes have tissue speciﬁc functions hinting at potential
roles for X-linked bi-allelic expression.
 Analysis of chromatin architecture at escape genes will lead to a better understanding of the
mechanisms underlying bi-allelic X-linked gene expression.2. Data, experimental design, materials and methods
Random inactivation of one of the X chromosomes in mammalian females takes place during early
development and is associated with Xist coating, accumulation of repressive histone modiﬁcations and
a speciﬁc alteration of chromatin architecture. A few genes escape random X inactivation and remain
bi-allelicly expressed throughout the life of the organism. This data is associated with the research
article focused on identifying escape genes in multiple tissue types in vivo, and on investigating a
mechanism that contributes to expression from the inactive X using a novel hybrid mouse model.
2.1. in vivo mouse model
Increased Xist expression during development is necessary for normal X inactivation. Several
regions of the Xist gene contain repetitive elements which are conserved between mouse and
humans. The proximal A-repeat has been shown to be necessary for Xist expression and thus, X
inactivation [2]. In order to derive a mouse model with skewed X inactivation, we took advantage of a
previously described mouse model in which the proximal A-repeat of Xist (XistΔ) was deleted (B6.Cg-
Xistotm5Sado4 , RIKEN [2]. We bred heterozygous C57BL/6 (BL6) females with the mutant Xist
(XistΔ/þ) to wild Mus spretus males. The mutant maternal X (Xm) fails to inactivate, thus the resulting
F1 females that inherited the mutant Xm have identiﬁable alleles and completely skewed X inacti-
vation in which the Xi is always the paternal spretus X (Xp) chromosome (Fig. 1).Fig. 1. F1 mouse model with skewed X inactivation and identiﬁable alleles. C57BL6 females with a Xist deletion [2] were mated
with wild-derivedMus spretusmales. In the resulting F1 females the BL6 maternal X chromosome that carries the Xistmutation
(XmXistΔ) cannot become inactivated, leading to complete skewing of X inactivation where the paternal spretus X chromosome
(Xp) is inactivated in all tissues. Shown are UCSC genome browser tracks of mRNA SNP read distribution proﬁles on the active
Xm (blue) and the inactive Xp (green) in brain, spleen and ovary at the Xist gene. Note that Xist is expressed from the spretus Xp
in all tissues analyzed.
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erozygous for the Xist mutation were euthanized at 8 wks of age. Chromatin, DNA and RNA from whole
brain, spleen and ovaries from mutant F1 females (XmXistΔ/Xp) were isolated according to the protocols
described below. Skewing of X inactivation was veriﬁed by Sanger sequencing as previously described [1].
2.2. in vitro cell culture
Patski cells were derived from the kidney of an 18dpc F1 female embryo from a cross between aM.
spretus male and a C57BL/6 female with an Hprt mutation. Brieﬂy, embryonic kidney cells were
selected in media containing hypoxanthine, aminopterin and thymidine (HAT). Only cells with a
functional Hprt gene are able to survive in HAT media. Thus, only F1 embryonic kidney cells that
contained a Xa from spretus and a Xi with the mutant allele (BL6Hprt) survived. X inactivation in the
selected cells (Patski cells) was completely skewed wherein the spretus X was always active [3]. After
selection, the Patski cell line was immortalized and was cultured in Dulbecco's Modiﬁed Eagle's
Medium (DMEM) with 10% FBS and 1% penicillin/streptomycin at 37 °C in 5% CO2.
2.3. RNA extraction and RNA-seq
Total RNA was extracted from homogenized XistΔ/þ hybrid tissues or from Patski cell pellets using
Qiagen's RNeasy mini kit (Qiagen 74104). For the RNA-seq library of Patski cells, the Illumina mRNA-
seq preparation kit was used in our previous study [4]. For the RNA-seq libraries of mouse tissues, we
used the Illumina TruSeq RNA preparation kit (Illumina RS-930-2001) with some slight modiﬁcations.
For mRNA isolation, 0.5–4 mg of total RNA was diluted into a total volume of 30 ml with nuclease free
water then combined with 30 ml of oligo dT magnetic beads. After incubation at 65 °C for 5 min, beads
were washed with 120 ml washing buffer and eluted with 30 ml elution buffer. Following a second
round of mRNA selection, mRNA was eluted and fragmented at 94 °C for 8 min. First-strand cDNA
synthesis, second-strand cDNA synthesis and end repair were performed according to the TruSeq
instructions except that all clean up steps were done using a Qiagen mini-elute columns (Qiagen
28004). A-tailing was done according to the TruSeq protocol incorporating the version 2 changes and
substituting AMpure XP beads with Qiagen mini-elute columns as described above. Further proces-
sing, including adapter ligation and fragment enrichment were done according to the TruSeq protocol
except that clean up steps were done with Qiagen columns. Libraries were sequenced using an
Illumina Genome Analyzer IIx generating 36 bp single-end reads with analyses described below.
2.4. Chromatin immunoprecipitation and ChIP-seq
In order to study the chromatin characteristics at escape genes in F1 tissues and Patski cells, we
carried out ChIP using speciﬁc antibodies for CTCF and RNA PolII-S5p, respectively. F1 tissues were
collected and homogenized in a pre-chilled 7 ml glass homogenizer in 5 ml PBS containing 0.1 mM
phenylmethylsulfonyl ﬂuoride (PMSF) on ice. The tissue homogenates were transferred to a 15 ml tube
and pelleted followed by re-suspension in 10 ml PBS. Samples were cross-linked in 1% formaldehyde for
10 min at room temperature and 125 mM ﬁnal concentration of glycine was added to quench cross-
linking. After washing with ice cold PBS containing 0.1 mM PMSF, cross-linked cells were re-suspended
in immuneprecipitation (IP) buffer [5] containing 0.1 mM PMSF and separated into 1 ml aliquots which
were either stored at 80 °C or lysed in IP buffer for 10 min on ice. For PolII-S5p ChIP, IP buffer per 1 ml
was also supplemented with the following phosphatase inhibitors: 10 ml of 1 M β-glycerophosphate,
and 10 ml of 1 M NaF, 1 ml of 100 mM Na3VO4. Shearing of chromatin was accomplished by sonication
(10 rounds of ﬁfteen 1 s pulses at power 6; 2 min rest on ice between rounds) using a Misonix 3000
sonicator. Chromatin concentration was measured using a Nanodrop followed by pre-clearing with
100 ml protein A beads (GE Healthcare Life Sciences) for 1 h at 4 °C. All of the steps described above
were also done for Patski cells with the exception of the initial homogenization.
For IP, 100 mg of cross-linked pre-cleared chromatin was combined with either 10 mg anti-CTCF
(Millipore, 07-729) or 5 mg PolII-S5p (Abcam, ab5131) antibodies and incubated in 1 ml IP buffer over
night at 4 °C with rotation. Ten percent of cross-linked pre-cleared chromatin (10 mg) was saved as the
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DNA-protein-antibody complexes, immunoprecipitated chromatin was incubated with 100 ml protein
A beads at 4 °C for 2 h with rotation followed by washes in buffers with varying concentrations of
salts (low salt: 0.1% SDS, 1% Triton-X-100, 20 mM EDTA, 20 mM Tris–HCl, 150 mM NaCl; high salt: 0.1%
SDS, 1% Triton-X-100, 20 mM EDTA, 20 mM Tris–HCl, 500 mM NaCl; LiCl buffer: 250 mM LiCl, 1% NP-
40, 1% deoxycholic acid, 1mM EDTA, 10 mM Tris pH 8.1) followed by two TE washes to remove any
residual salt. All wash steps were done at 4 °C. Complexes were eluted from the beads in elution
buffer (1% SDS; 100 mM NaHCO3) 2 times for 20 min each at room temperature. To reverse the cross-
links, eluted complexes were incubated in elution buffer supplemented with 200 mM NaCl overnight
at 65 °C. ChIP'd DNAwas puriﬁed using QIAquick PCR puriﬁcation columns (Qiagen 28106). An aliquot
of ChIP and input DNA subjected to PCR for the housekeeping gene β-actin to conﬁrm speciﬁcity of
the pull-down compared to the no-antibody mock ChIP control.
Puriﬁed DNA from CTCF or PolII-S5p ChIP experiments in brain as well as PolII-S5p ChIP experiments in
Patski cells were used for library preparation according to the Illumina TruSeq ChIP preparation protocol,
with the exception that all AMPure XP bead puriﬁcation steps were replaced by Qiagenmini-elute columns.
Brieﬂy, ChIP DNAwas repaired to generate blunt ends followed by the addition of an “A” nucleotide to each
end. Adapters were ligated and 300–650 bp size fragments were selected in a 1.5% low-melting agarose gel
followed by column puriﬁcation. After PCR enrichment of puriﬁed fragments, completed libraries were
sequenced on an Illumina HiSeq 2000 machine. Puriﬁed DNA from CTCF ChIP experiments in Patski cells
was used for library preparation according to the Illumina genomic DNA preparation protocol and
sequenced on an Illumina Genome Analyzer IIx. Sequenced libraries were analyzed as described below.
2.5. Mapping and allele-assignment of sequencing reads
To identify reads that map to each parental genome of the F1 mice, we ﬁrst assembled a "pseudo-
spretus" genome by substituting known SNPs of spretus into the BL6 NCBIv37/mm9 reference genome.
Spretus SNPs were obtained from the Sanger Institute (SNP database Nov/2011 version) and from in house
analysis [4]. In total, we collected 1,532,011 heterozygous SNPs on the X chromosome and 31,062 of them
were located in exonic regions. A more detailed breakdown of SNP location can be found in Table 2.
Reads from genomic DNA sequencing, ChIP-seq, and DNaseI-seq experiments were mapped
separately to the BL6 reference sequence (mm9) and to the pseudo-spretus genome using BWA/v0.5.9
[6] with default parameters. RNA-seq reads from tissue samples were mapped to both the BL6 and the
pseudo-spretus genomes and transcriptomes using Tophat/v2.0.2 [7] with default parameters. We
segregated all high-quality (MAPQZ30) uniquely mapped reads into three categories: (1) BL6-SNP
reads containing only BL6-speciﬁc SNP(s); (2) spretus-SNP reads containing only spretus-speciﬁc SNP
(s); (3) allele-uncertain reads, that is, reads that do not contain valid SNPs (Table 3). We refer to both
BL6-SNP reads and spretus-SNP reads as "allele-speciﬁc reads".
2.6. RNA-seq analysis and identiﬁcation of escape genes
We calculated diploid gene expression based on all high-quality uniquely mapped reads using
cufﬂinks/v2.0.2 [8] to determine the gene-level RPKM (reads per kb of exon length per million
mapped reads) expression values. In addition, we deﬁned SNP-based haploid gene expression fromTable 2
SNP location summary.
Location Total SNPsa Number of genes with exonic SNPsb
X chromosome 1,532,011 (4.3%) 1099 (73.6%)
Autosomes 33,909,724 (95.7%) 27,010 (93.1%)
Both 35,441,735 (100%) 28,109 (92.1%)
a Total number of SNPs at the corresponding chromosomal locations (X, autosomes or both).
b Number of genes with exons containing SNPs at the corresponding chromosomal locations (X, autosomes or both).
Table 3
Mapped reads summary.
Sample Experiment Replicate Length (bp) Raw reads % uniquea % BL6b % spretusb % uncertainb Ratioc
Brain RNA-seq 1 36 104,241,363 80 11 10 78 1.1
Brain RNA-seq 2 36 36,430,212 86 12 11 77 1.1
Spleen RNA-seq 1 36 88,842,032 73 12 11 77 1.07
Spleen RNA-seq 2 36 32,538,760 72 12 11 76 1.07
Ovary RNA-seq 1 36 78,210,224 77 11 11 78 1.06
Patski RNA-seq 1 36 33,784,231 79 11 10 79 1.04
Patski RNA-seq 2 36 27,196,142 67 10 10 80 1.04
Brain CTCF ChIP-seq 1 100 552,106,670 51 43 30 27 1.43
Patski CTCF ChIP-seq 1 36 87,390,982 56 22 20 58 1.13
Brain PolII ChIP-seq 1 100 301,496,879 44 40 32 28 1.26
Patski PolII ChIP-seq 1 36 132,743,111 48 22 20 58 1.11
Patski Dnase-seq 1 36 36,361,296 65 18 17 65 1.09
Patski Dnase-seq 2 36 38,191,194 68 19 18 63 1.09
a Percent of uniquely mapped reads calculated over the number of raw reads.
b Percents of BL6, spretus and allele-uncertain reads calculated over the number of high-quality uniquely mapped reads. %
BL6 and % spretus reads represent reads containing only BL6 or spretus SNPs, respectively. % uncertain reads represents reads
that contained no valid SNPs.
c Ratios were calculated as BL6-SNP reads/ spretus-SNP reads.
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10 million high-MAPQ uniquely mapped reads.
To identify escape genes and estimate the statistical conﬁdence of escape probability of X-linked
genes, we developed the following binomial model. For each gene i on chromosome X, let the number
of allele-speciﬁc RNA-seq reads mapped to the inactive/active chromosomes be ni0 and ni1, respec-
tively, and let ni ¼ ni0þni1. We model ni0 by a binomial distribution:
ni0  Binomialðni; piÞ;
where pi indicates the expected proportion of reads from the Xi. The estimate of the binomial
proportion is p^i ¼ ni0ni . Let zα2 be the 100 1
α
2
 th percentile of N(0,1). The conﬁdence interval of each p^i
is p^i7zα2
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
p^i 1 p^ið Þ
ni
r
.
Inclusion of a mapping bias correction was necessary since our model utilizes distantly related
mouse species and prevents analysis of reciprocal crosses [1]. To incorporate the mapping biases
toward the BL6 genome over the pseudo-spretus genome into the above model, we deﬁne the
mapping bias ratio rm for each RNA-seq experiment to be rm ¼ NA0NA1, where NA0 and NA1 are the number
of allele-speciﬁc autosomal reads in the "inactive X containing" genome and the "active X containing"
genome, respectively. Considering the mapping biases, the corrected estimate of pi is
pi ¼ ni0ni0 þ rmni1ð Þ ¼
p^i
p^i þ rm 1 p^ið Þð Þ. The upper and lower conﬁdence limits are corrected accordingly.
For each RNA-seq experiment, we deﬁned an X-linked gene as an "escape" gene using the fol-
lowing three criteria: (1) the 99% lower conﬁdence limit (α¼0.01) of the escape probability pi was
greater than zero, (2) the diploid gene expression measured by RPKM was Z1, indicating that the
gene was expressed, and (3) the normalized Xi-SRPM was Z2 but o5 (low-level escape) or Z5
(high-level escape). Biological replicates of RNA-seq experiments were analyzed separately. The Xi-
SRPM values are highly correlated between biological replicates (R240.9) (Fig. 2).
2.7. ChIP-seq analysis
For CTCF and PolII-S5p ChIP-seq data, we ﬁrst used all high-MAPQ uniquely mapped reads to
identify enriched peak regions in the diploid genome. Two independent peak calling programs were
applied, CisGenome (FDR cutoff 105) [9,10] and MACS/v1.4 (p-value cutoff 105) [11]. We deﬁned
signiﬁcantly enriched peak regions as those identiﬁed by both peak callers (Table 4).
Fig. 2. Scatter plots showing data reproducibility of RNA-seq in tissues and cells. Plots represent expression levels from the X
chromosome in replicate 1 (rep1) versus expression levels from the X chromosome in replicate 2 (rep2).
Table 4
ChIP-seq peak numbers.
Sample Protein Total peaksa Total X-linked peaksb Xa-preferredc Xi-preferredc Both-preferredc
Brain CTCF 119,860 2508 1060 211 365
Patski CTCF 27,810 606 126 86 160
Brain PolIIS5p 58,576 792 133 37 267
Patski PolIIS5p 45,714 550 180 80 86
a Number of total peaks identiﬁed.
b Number of peaks present on the X chromosomes.
c Number of peaks preferred on the Xa, Xi or both.
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ChIP-seq peak region i, we assumed that the numbers of BL6-SNP reads (ni;bl) and spretus-SNP reads
(ni;sp) within the peak follow a binomial distribution, i.e.,
ni;bl  Binomial ni; pi
 
;
where ni ¼ ni;blþni;sp is the sum of BL6-SNP reads and spretus-SNP reads in peak region i, and pi is the
binomial parameter. Since the X chromosome behaves differently from autosomes due to skewed XCI
in our systems, we estimated the X chromosome allelic background using all SNP reads in the
identiﬁed diploid peak regions on the X only. That is, for peaks on the X chromosome,
pi ¼ pX ¼
NX;bl
NX;blþNX;sp
  ;
in which NX;bl and NX;sp are the total number of BL6-SNP and spretus-SNP reads in X peaks, respec-
tively. Finally, BL6-preferred ChIP-seq peaks were deﬁned as those that contain signiﬁcantly more
BL6-SNP reads (upper-tail binomial test, p-valueo0.05), while spretus-preferred ChIP-seq peaks were
identiﬁed using the lower-tail binomial test (p-valueo0.05), and both-preferred ChIP-seq peaks were
those peaks that were not signiﬁcant in the two above tests (p-valueZ0.25) (Table 4). In addition, we
required the allele-assessable peaks have a minimal SNP read coverage of one allele-speciﬁc read
(BL6-SNP and spretus-SNP reads) per 10 million mapped reads.Acknowledgments
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